Dexmedetomidine + Ketamine for Anesthesia Study

This trial explores brain function during different levels of anesthesia using either dexmedetomidine (a sedative) or ketamine (an anesthetic), both common drugs. The researchers aim to identify which brain regions remain active under anesthesia. The trial involves healthy, right-handed individuals who have played racquet sports at least 30 times and have a BMI under 30. Participants will be divided into groups, with each group receiving one of the drugs while undergoing an fMRI scan. This research could enhance anesthesia use in surgeries. As a Phase 2 trial, it focuses on measuring the treatment's effectiveness in an initial, smaller group, allowing participants to contribute to advancements in anesthesia safety and effectiveness.

Research has shown that both dexmedetomidine and ketamine are generally safe, but some considerations are necessary. Studies have found that dexmedetomidine can cause side effects such as changes in blood pressure and heart rate. It is typically safe and effective for calming patients, especially during procedures like MRIs, but caution is advised for those with heart or liver issues.

Ketamine carries a low risk of causing breathing problems at low doses, making it relatively safe. Most studies have found few serious side effects, though ketamine can cause temporary behavioral changes, similar to psychosis, at certain doses.

Researchers are excited about using Dexmedetomidine and Ketamine for anesthesia because they offer unique benefits compared to traditional options like propofol or opioid-based anesthetics. Dexmedetomidine works by selectively targeting alpha-2 adrenergic receptors, which can lead to sedation without respiratory depression, a common concern with many anesthetics. Ketamine, on the other hand, acts as an NMDA receptor antagonist, providing not just anesthesia but also analgesia and potentially reducing post-operative pain. Together, these treatments could offer a safer and more effective alternative, minimizing side effects and improving recovery times.

Research has shown that dexmedetomidine, which participants in this trial may receive, aids in sedation and pain relief without impacting breathing. It also enhances recovery after surgery and reduces the need for other anesthetics like propofol. Meanwhile, ketamine, another treatment option in this trial, effectively manages sedation and pain, particularly in short medical procedures. It can reduce the need for strong painkillers and may shorten hospital stays. Both treatments help maintain patient comfort and calmness during procedures.⁶⁷⁸⁹¹⁰